Rosengart
Frank Rosengart, Zurich DE
Patent application number | Description | Published |
---|---|---|
20110170838 | METHOD FOR DISTRIBUTING SECOND MULTI-MEDIA CONTENT ITEMS IN A LIST OF FIRST MULTI-MEDIA CONTENT ITEMS - A method of distributing second multi-media content items into a list having at least one first multi-media content item is provided. The list of the first multi-media content item is to be reproduced on a personal TV system. A playlist of first multi-media content items is selected from a plurality of first multi-media content items available on different TV channels. Potential second multi-media content items from a plurality of available second multi-media content items are determined by matching information from the first and second multi-media content items. At least one of the determined second multi-media content items are selected based on a user profile, metadata of the first and second multi-media content items and/or a distribution scheme for distributing the second multi-media content items into the playlist of the first multi-media content items. | 07-14-2011 |
Frank Rosengart, Zurich CH
Patent application number | Description | Published |
---|---|---|
20120316934 | ADAPTIVE PLACEMENT OF AUXILIARY MEDIA IN RECOMMENDER SYSTEMS - The present invention relates to an apparatus, method, and computer program product for controlling a recommender system, wherein placement of auxiliary media in relation to at least one content item presented to a user is controlled. A first scheduler ( | 12-13-2012 |
Todd K. Rosengart, Bellaire, TX US
Patent application number | Description | Published |
---|---|---|
20150290290 | ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM - Provided is a method of treating coronary artery disease in a mammal, comprising administering to a region of the heart of the mammal (a) a first vector encoding one or more angiogenic proteins which induce vascularization in the heart of the mammal, and (b) a second vector encoding one or more cardio-differentiating transcription factors which induce the production of induced cardiomyocytes (iCM) in the heart of the mammal, whereby the coronary artery disease in the mammal is treated. In a preferred embodiment, the first vector is an adenoviral vector encoding VEGF and the second vector is a lentiviral vector encoding Gata4, Mef2c, and Tbx5 (GMT). | 10-15-2015 |